New DAA Hepatitis C Drugs
New Direct Acting Antiviral drugs, such as Harvoni, Sofosbuvir and Boceprevir have been approved by NICE.20 Feb 2016
The guidance in October 2015 gave the NHS three months to implement the recommendation. This means that all chronic Hepatitis C sufferers in England should be able to access treatment by the end of February 2016.
Doctors can lead the way to healthier drug policies – join IDHDP nowShare this on: